BAM
MRNA

Byrne Asset Management’s MARINA BIOTECH INC COM STK (DE) MRNA Stock Holding History

Byrne Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7K Sell
438
-100
-19% -$7K 0.02% 330
2026
Q1 		$27.3K Sell
538
-10
-2% -$508 0.02% 321
2025
Q4 		$16.2K Buy
548
+490
+845% +$14.5K 0.01% 372
2025
Q3 		$1.5K Sell
58
-40
-41% -$1.03K ﹤0.01% 526
2025
Q2 		$2.7K Sell
98
-15
-13% -$414 ﹤0.01% 496
2025
Q1 		$3.2K Sell
113
-65
-37% -$1.84K ﹤0.01% 502
2024
Q4 		$7.4K Sell
178
-70
-28% -$2.91K 0.01% 425
2024
Q3 		$16.6K Sell
248
-123
-33% -$8.22K 0.01% 328
2024
Q2 		$45K Sell
371
-50
-12% -$6.06K 0.03% 211
2024
Q1 		$44.9K Hold
421
– – 0.03% 210
2023
Q4 		$42.4K Sell
421
-372
-47% -$37.5K 0.03% 206
2023
Q3 		$82K Buy
+793
New +$82K 0.07% 160

Byrne Asset Management's MRNA Position: Q2 2026 in Review

Byrne Asset Management reduced its MARINA BIOTECH INC COM STK (DE) (MRNA) stake by 19% in Q2 2026, selling an estimated $7K and leaving 438 shares worth $30.7K. The position accounts for 0.02% of the portfolio, ranked #330.

Byrne Asset Management first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $82K in Q3 2023. 1 fund tracked by Wall St. Rank holds MRNA as of Q2 2026.

  • Byrne Asset Management held 438 shares of MARINA BIOTECH INC COM STK (DE) worth $30.7K as of Q2 2026.
  • Byrne Asset Management sold 100 MARINA BIOTECH INC COM STK (DE) shares in Q2 2026, an estimated $7K.
  • MARINA BIOTECH INC COM STK (DE) made up 0.02% of Byrne Asset Management's portfolio in Q2 2026, its #330 holding.
  • Byrne Asset Management first reported a position in MARINA BIOTECH INC COM STK (DE) in Q3 2023 and has held it in 12 quarters since.
  • Byrne Asset Management's MARINA BIOTECH INC COM STK (DE) position peaked at $82K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held MARINA BIOTECH INC COM STK (DE) as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.